Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The products sold on this website are not intended to diagnose, treat, restore, correct or modify any functions in human beings
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have become common therapies in the management of chronic conditions such as diabetes and obesity
This could complement treatments specifically aimed at psoriatic arthritis, giving patients broader symptom relief
Most evidence comes from secondary analyses of diabetes and obesity trials where joint symptoms were not primary endpoints
Consent for Publication All authors have read the manuscript and approved its submission
Brand-name products often cost $900$1,400 monthly without insurance coverage, placing GLP-1 therapy out of reach for working-class and middle-income families
